Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells
Daniel A. Lichtenstein(National Institutes of Health), Nirali N. Shah(National Institutes of Health), Constance M. Yuan(National Cancer Institute), Terry J. Fry(University of Colorado Anschutz Medical Campus), Francesco Ceppi(University of Lausanne), Lipei Shao(National Institutes of Health Clinical Center), Fiorella Schischlik(National Cancer Institute), Jon R. Inglefield(Frederick National Laboratory for Cancer Research), Bonnie Yates(National Institutes of Health), Seth M. Steinberg(National Institutes of Health), Leandro C. Hermida(National Cancer Institute), Karen M. Chisholm(Seattle Children's Hospital), Jianjian Jin(National Institutes of Health Clinical Center), Welles Robinson(National Cancer Institute), Amanda K. Ombrello(National Human Genome Research Institute), Philip Homan(National Institutes of Health), Maryalice Stetler‐Stevenson(National Cancer Institute), Justin Mirazee(National Institutes of Health), Parthav Jailwala(National Institutes of Health), Haneen Shalabi(Center for Cancer Research), Kate Stringaris(National Heart Lung and Blood Institute), David F. Stroncek(Yale University), Kim Dunham(Frederick National Laboratory for Cancer Research), Rebecca Gardner(Seattle Children's Hospital), Ping Jin(Zhejiang Chinese Medical University), Hao‐Wei Wang(Fu Jen Catholic University), Yanyu Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Alina Dulau-Florea(National Institutes of Health), Naomi Taylor(National Institutes of Health), Eytan Ruppin(National Institutes of Health), Steven L. Highfill(National Institutes of Health)
Cited by 194
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2
|New England Journal of Medicine|2014|889
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
|Journal of Hepatology|2016|817
IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion
|Genes & Development|2010|744